Microbial natural-product manufacturing is usually optimized as though one dominant limitation can be identified, corrected, and then managed through scale-up. That assumption is increasingly difficult to sustain because pathway capacity, precursor allocation, product or intermediate toxicity, oxygen and substrate delivery, mixing, energy demand, and recovery can become restrictive at different process states and reactor scales. This article develops an original bioprocess architecture in which fermentation failure is treated as a changing constraint-identification problem rather than a fixed bottleneck problem. The analysis integrates evidence from natural-product cell-factory engineering, large-scale gradient characterization, scale-down perturbation studies, dynamic metabolic control, process analytical technology, hybrid state estimation, predictive control, and in situ recovery. The central contribution is a proposed constraint-switching architecture that separates candidate constraint classes from their observables, infers an active constraint with explicit uncertainty, and links that diagnosis to distinct actions in feeding, induction, process operation, or recovery before re-evaluation. The architecture is intended to preserve biological and engineering distinctions that are often collapsed in conventional scale-up reasoning. It does not assume that every fermentation has one uniquely identifiable constraint, that switching is always beneficial, or that an intervention resolving one limitation improves total process performance. Its principal value is therefore organizational and testable: it defines what must be monitored, distinguished, challenged, and validated before adaptive control of microbial natural-product production can be claimed across scale.
